Mycohsa
Commercial- Indications
- Digestive health, Immune health
Company intelligence / Profile preview
Biohm Technologies has developed clinically validated probiotic ingredients and gut health solutions. Their flagship product Mycohsa™ has been shown in clinical studies to break down digestive biofilms and support optimal levels of both bacteria and yeasts in the gut. The company’s products are supported by a large proprietary dataset from at-home microbiome testing kits. They have shifted focus toward B2B offerings while maintaining direct-to-consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biohm Technologies.